1990
DOI: 10.1073/pnas.87.23.9073
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of the human 5-lipoxygenase gene promoter.

Abstract: Nucleotide sequences that direct transcription of the human 5-lipoxygenase gene have been examined by ligation to the chloramphenicol acetyltransferase gene and determination of chloramphenicol acetyltransferase activity in transfected HeLa and HL-60 cells. Various lengths of 5'-flanking sequences up to 5.9 kilobase pairs 5' of the transcriptional initiation sites were tested. Two positive and two negative apparent regulatory regions were seen. Part of the promoter sequence (-179 to -56 from ATG), which includ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
96
0

Year Published

1998
1998
2002
2002

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 129 publications
(96 citation statements)
references
References 30 publications
0
96
0
Order By: Relevance
“…Of particular importance, Hoshiko et al 75 have identified a GϩC-rich sequence, between Ϫ212 and Ϫ88 bp relative to the translational start site, as being necessary for promoter-reporter construct activity in HeLa and HL-60 cells; these observations, which we have confirmed, led us to examine this region of the ALOX5 promoter for mutations that might alter gene transcription. We identified a family of naturally occurring mutations that alter Sp1 and Egr-1 consensus binding sites by the addition of one or the deletion of one or two -GGGCGGsequences ( Figure 7).…”
Section: Pharmacogenetics Of Leukotrienes In Asthmamentioning
confidence: 85%
“…Of particular importance, Hoshiko et al 75 have identified a GϩC-rich sequence, between Ϫ212 and Ϫ88 bp relative to the translational start site, as being necessary for promoter-reporter construct activity in HeLa and HL-60 cells; these observations, which we have confirmed, led us to examine this region of the ALOX5 promoter for mutations that might alter gene transcription. We identified a family of naturally occurring mutations that alter Sp1 and Egr-1 consensus binding sites by the addition of one or the deletion of one or two -GGGCGGsequences ( Figure 7).…”
Section: Pharmacogenetics Of Leukotrienes In Asthmamentioning
confidence: 85%
“…Deletional and mutational analyses of the 5-lipoxygenase promoter in a reporter construct revealed a GC-rich region that is important for transcription (28). Gel shift assay demonstrated that a 5 tandem repeat sequence in the GC-rich region bound to transcription factors Sp1 and Egr-1 (30), both of which transactivate the 5-lipoxygenase promoter in SL2 cells (31).…”
Section: Discussionmentioning
confidence: 99%
“…Like LTC 4 S, LTA 4 hydrolase and 5-lipoxygenase are also TATA-less genes (28,29). Deletional and mutational analyses of the 5-lipoxygenase promoter in a reporter construct revealed a GC-rich region that is important for transcription (28).…”
Section: Discussionmentioning
confidence: 99%
“…In Mono Mac 6 cells, the induction of 5-LO protein expression and activity by TGF␤ and 1,25(OH) 2 D 3 was accompanied by a 64-fold up-regulation of mature 5-LO mRNA and an up to 5-fold increase in 5-LO primary transcripts (7,8), whereas no significant induction of 5-LO transcription was found in nuclear run-off assays (9). The human 5-LO gene promoter was first characterized by Hoshiko et al (10). Several features of the putative 5-LO promoter region (such as the lack of TATAA or CCAAT boxes and repeated (GϩC)-rich elements) are characteristic for so-called housekeeping genes.…”
mentioning
confidence: 99%
“…Several features of the putative 5-LO promoter region (such as the lack of TATAA or CCAAT boxes and repeated (GϩC)-rich elements) are characteristic for so-called housekeeping genes. Previous data suggest that the transcription factors Egr-1 and/or Sp1 are required for basal 5-LO transcription and that they functionally interact with the 5-LO promoter and activate it via repeated response elements located between positions Ϫ212 and Ϫ88 bp, relative to the translational start site (10,11). Interestingly, naturally occurring mutations were found in the 5-LO promoter consisting of the deletion of one or two, or the addition of one Sp1 binding site (12).…”
mentioning
confidence: 99%